Clinical Trials Browser

Phase NA × Carcinoma, Hepatocellular × Hematologic Tests × Clear all

NCT01492127 2015-04-23

Evaluation of Proteasome as a Marker of Hepatocellular Carcinoma in Cirrhotic Patients Following Curative Treatment

Phase NA Unknown

Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular